Covit-19, which has affected the whole world for about a year, is a life-threatening virus with high activity that causes serious deaths.
Covit-19 is life-threatening as a serious problem that causes death if it cannot be intervened for this reason, which especially affects the lungs.
Covit-19 affects the lungs, affects the heart, impairs the nervous system, leaves the immune deficiency.
Covit-19, which has an increased chance of being controlled with the discovery of the vaccine, can bring some patients to the point of intubation.
When the lungs need oxygen supplementation, a hose is sent to the lung when there is a problem in delivering oxygen, so the ventilator device transmits oxygen to the lungs more easily. intubated patient is put to sleep naturally. THREE THREE OF THE PATIENTS IN THE INTUBE CONDITION HAVE CORRECTED AND COMBINED TO THEIR HEALTH.
The intubated patient can stay in that state for weeks. This process can bring many risks together. Among them, multiple organ failure is one of the leading ones.
In this process, the Ministry of Health drug protocol is applied. There is currently no definitive therapeutic drug of kovit19. It is trying to create a complete treatment from existing drugs. Ozone therapy, stem cell transplantation can be life saving in intubated patients! conventional intensive care practices may not be enough.!
Covit-19 continues to threaten life as a very serious problem.
Vaccination applications provide six months protection but do not destroy the germ. The vaccinated person will continue to spread microbes even if their illness is not severe.
Among the vaccines, interactive vaccines called dead vaccines should be preferred because they have few side effects.
Contrary to popular belief, the elderly and children with chronic diseases are vulnerable and should be the precursors of vaccination programs.
Covit-19 demands a seriousness that requires the public to be conscious. It will be difficult to prevent this process from going negatively with only the efforts of the Ministry of Health.